Modernste Bildgebung zur Diagnose von Knochenmetastasen

Amanda Isaac; Danoob Dalili; Daniel Dalili; Marc André Weber

doi:10.1007/s00117-020-00666-6

Modernste Bildgebung zur Diagnose von Knochenmetastasen

Translated title of the contribution: State-of-the-art imaging for diagnosis of metastatic bone disease

Amanda Isaac^*, Danoob Dalili, Daniel Dalili, Marc André Weber

^*Corresponding author for this work

Biomedical Engineering Department

Research output: Contribution to journal › Review article › peer-review

24 Citations (Scopus)

Abstract

Metastatic bone disease (MBD) is common—it is detected in up to 65–75% of patients with breast or prostate cancer, in over 35% of patients with lung cancer; and almost all patients with symptomatic multiple myeloma have focal lesions or a diffuse bone marrow infiltration. Metastatic bone disease can cause a variety of symptoms and is often associated with a poorer prognosis, with high social and health-care costs. Population-based cohort studies confirm significantly increased health-care utilization costs in patients presenting with cancer with MBD compared with those without MBD. The prolonged survival of patients with bone metastasis thanks to advances in therapy presents an opportunity for better treatments for this patient cohort. Early and accurate diagnosis of bone metastases is therefore crucial. The patterns and presentation of MBD are quite heterogeneous and necessitate good knowledge of the possibilities and limitations of each imaging modality. Here, we review the state-of-the-art imaging techniques, assess the need for evidence-based and cost-effective patient care pathways, and advocate multidisciplinary management based on collaborations between orthopedic surgeons, pathologists, oncologists, radiotherapists, and radiologists aimed at improving patient outcomes. Radiologists play a key role in this multidisciplinary approach to decision-making through correlating the tumor entity, the tumor biology, the impact on the surrounding tissues and progression, as well as the overall condition of the patient. This approach helps to choose the best patient-tailored imaging plan advocating a “choose wisely” strategy throughout the initial diagnosis, minimally invasive treatment procedures, as well as follow-up care plans.

Translated title of the contribution	State-of-the-art imaging for diagnosis of metastatic bone disease
Original language	German
Journal	Radiologe
Volume	60
DOIs	https://doi.org/10.1007/s00117-020-00666-6
Publication status	Published - Nov 2020

Keywords

Bone
Health-care costs
Imaging
Metastasis
Skeletal
Whole-body

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00117-020-00666-6

Cite this

@article{dc97f8a22fc54df19a756df00c995352,

title = "Modernste Bildgebung zur Diagnose von Knochenmetastasen",

abstract = "Metastatic bone disease (MBD) is common—it is detected in up to 65–75% of patients with breast or prostate cancer, in over 35% of patients with lung cancer; and almost all patients with symptomatic multiple myeloma have focal lesions or a diffuse bone marrow infiltration. Metastatic bone disease can cause a variety of symptoms and is often associated with a poorer prognosis, with high social and health-care costs. Population-based cohort studies confirm significantly increased health-care utilization costs in patients presenting with cancer with MBD compared with those without MBD. The prolonged survival of patients with bone metastasis thanks to advances in therapy presents an opportunity for better treatments for this patient cohort. Early and accurate diagnosis of bone metastases is therefore crucial. The patterns and presentation of MBD are quite heterogeneous and necessitate good knowledge of the possibilities and limitations of each imaging modality. Here, we review the state-of-the-art imaging techniques, assess the need for evidence-based and cost-effective patient care pathways, and advocate multidisciplinary management based on collaborations between orthopedic surgeons, pathologists, oncologists, radiotherapists, and radiologists aimed at improving patient outcomes. Radiologists play a key role in this multidisciplinary approach to decision-making through correlating the tumor entity, the tumor biology, the impact on the surrounding tissues and progression, as well as the overall condition of the patient. This approach helps to choose the best patient-tailored imaging plan advocating a “choose wisely” strategy throughout the initial diagnosis, minimally invasive treatment procedures, as well as follow-up care plans.",

keywords = "Bone, Health-care costs, Imaging, Metastasis, Skeletal, Whole-body",

author = "Amanda Isaac and Danoob Dalili and Daniel Dalili and Weber, {Marc Andr{\'e}}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = nov,

doi = "10.1007/s00117-020-00666-6",

language = "German",

volume = "60",

journal = "Radiologe",

issn = "0033-832X",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Modernste Bildgebung zur Diagnose von Knochenmetastasen

AU - Isaac, Amanda

AU - Dalili, Danoob

AU - Dalili, Daniel

AU - Weber, Marc André

PY - 2020/11

Y1 - 2020/11

N2 - Metastatic bone disease (MBD) is common—it is detected in up to 65–75% of patients with breast or prostate cancer, in over 35% of patients with lung cancer; and almost all patients with symptomatic multiple myeloma have focal lesions or a diffuse bone marrow infiltration. Metastatic bone disease can cause a variety of symptoms and is often associated with a poorer prognosis, with high social and health-care costs. Population-based cohort studies confirm significantly increased health-care utilization costs in patients presenting with cancer with MBD compared with those without MBD. The prolonged survival of patients with bone metastasis thanks to advances in therapy presents an opportunity for better treatments for this patient cohort. Early and accurate diagnosis of bone metastases is therefore crucial. The patterns and presentation of MBD are quite heterogeneous and necessitate good knowledge of the possibilities and limitations of each imaging modality. Here, we review the state-of-the-art imaging techniques, assess the need for evidence-based and cost-effective patient care pathways, and advocate multidisciplinary management based on collaborations between orthopedic surgeons, pathologists, oncologists, radiotherapists, and radiologists aimed at improving patient outcomes. Radiologists play a key role in this multidisciplinary approach to decision-making through correlating the tumor entity, the tumor biology, the impact on the surrounding tissues and progression, as well as the overall condition of the patient. This approach helps to choose the best patient-tailored imaging plan advocating a “choose wisely” strategy throughout the initial diagnosis, minimally invasive treatment procedures, as well as follow-up care plans.

AB - Metastatic bone disease (MBD) is common—it is detected in up to 65–75% of patients with breast or prostate cancer, in over 35% of patients with lung cancer; and almost all patients with symptomatic multiple myeloma have focal lesions or a diffuse bone marrow infiltration. Metastatic bone disease can cause a variety of symptoms and is often associated with a poorer prognosis, with high social and health-care costs. Population-based cohort studies confirm significantly increased health-care utilization costs in patients presenting with cancer with MBD compared with those without MBD. The prolonged survival of patients with bone metastasis thanks to advances in therapy presents an opportunity for better treatments for this patient cohort. Early and accurate diagnosis of bone metastases is therefore crucial. The patterns and presentation of MBD are quite heterogeneous and necessitate good knowledge of the possibilities and limitations of each imaging modality. Here, we review the state-of-the-art imaging techniques, assess the need for evidence-based and cost-effective patient care pathways, and advocate multidisciplinary management based on collaborations between orthopedic surgeons, pathologists, oncologists, radiotherapists, and radiologists aimed at improving patient outcomes. Radiologists play a key role in this multidisciplinary approach to decision-making through correlating the tumor entity, the tumor biology, the impact on the surrounding tissues and progression, as well as the overall condition of the patient. This approach helps to choose the best patient-tailored imaging plan advocating a “choose wisely” strategy throughout the initial diagnosis, minimally invasive treatment procedures, as well as follow-up care plans.

KW - Bone

KW - Health-care costs

KW - Imaging

KW - Metastasis

KW - Skeletal

KW - Whole-body

UR - http://www.scopus.com/inward/record.url?scp=85083376994&partnerID=8YFLogxK

U2 - 10.1007/s00117-020-00666-6

DO - 10.1007/s00117-020-00666-6

M3 - Review article

C2 - 32211916

AN - SCOPUS:85083376994

SN - 0033-832X

VL - 60

JO - Radiologe

JF - Radiologe

ER -

Modernste Bildgebung zur Diagnose von Knochenmetastasen

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this